2023 ISAKOS Biennial Congress ePoster
Preoperative Opioid Use is Associated with Worse Baseline Measures in Hip Arthroscopy Patients
Michael Rocca, MD, Baltimore, MD UNITED STATES
Evan L. Honig, BA, Baltimore, Maryland UNITED STATES
Andrew Tran, MD, Baltimore, Maryland UNITED STATES
Matthew Kolevar, MD, Baltimore, Maryland UNITED STATES
Samir Kaveeshwar, MD, Baltimore, Maryland UNITED STATES
Ali Aneizi, MD, Baltimore, Maryland UNITED STATES
Natalie Luanne Leong, MD, Los Angeles, CA UNITED STATES
Jonathan D. Packer, MD, Baltimore, MD UNITED STATES
R Frank Henn, MD, Baltimore, MD UNITED STATES
Sean J. Meredith, MD, Baltimore, Maryland UNITED STATES
University of Maryland , Baltimore, Maryland, UNITED STATES
FDA Status Not Applicable
Summary
Nearly 20% of hip arthroscopy patients were taking opioid medications prior to surgery and those patients taking opioids preoperatively had significantly worse baseline physical function, pain, social satisfaction, and depression than those who did not use preoperative opioids.
ePosters will be available shortly before Congress
Abstract
Introduction
As hip arthroscopy has dramatically grown in recent years, it is increasingly important to utilize patient reported outcomes (PROs) to help guide clinical practice. Despite the growing literature on hip arthroscopy, there is limited literature on the association between PROs in hip arthroscopy and preoperative opioid usage. The purpose of this study was to evaluate the rate of preoperative opioid usage and its association with preoperative PROs.
Methods
A single institution orthopaedic registry was retrospectively analyzed. All patients undergoing hip arthroscopy from 2015 to 2022 were analyzed. Patients were administered the Patient-Reported Outcomes Measurement Information System (PROMIS) in six domains, Numeric Pain Scores, and Musculoskeletal Outcomes Data Evaluation and Management System (MODEMS) Expectations domain preoperatively. Patients’ charts were reviewed to determine demographic factors and preoperative opioid use within 6 weeks of surgery. Bivariate analysis was used to determine associations between preoperative opioid use and baseline PROs. Significant bivariate associations were further tested by multivariate analysis to determine independent predictors.
Results
Of the 123 patients included in the study, 21 patients (17%) were taking opioid mediations preoperatively. Prior orthopaedic or other surgeries were significantly associated with preoperative opioid use, but prior hip surgery was not associated. Patients with preoperative opioid use scored significantly worse on preoperative PROMIS Physical Function (PF; 38.6±4.9 versus 40.5±6.9; p = 0.011), Pain Interference (PI; 65.9±8.0 versus 60.2±6.1; p = 0.001), Fatigue (60.7±12.4 versus 51.6±10.1; p = 0.005), Social Satisfaction (SS; 38.2±7.6 versus 43.2±7.5; p = 0.007), and Depression (54.2±11.0 versus 48.8±9.0; p = 0.012) compared to those without preoperative opioid use. Preoperative opioid use was also associated with significantly worse Numeric Pain Scores for both the operative hip (6.3±2.4 versus 4.6±2.3; p = 0.003) and whole body (3.0±2.7 versus 1.4±2.0; p = 0.008). On multivariate analysis, preoperative opioid use was an independent predictor of worse baseline PROMIS PI, Fatigue and SS scores and Numeric Pain Score for the operative hip.
Conclusion
Hip arthroscopy patients with preoperative opioid use had significantly worse baseline PROs for physical function, pain, social satisfaction, and depression than those who did not use preoperative opioids. When controlling for confounding variables, preoperative opioid use was predictive of worse baseline pain, fatigue and social satisfaction. Preoperative opioid use should be recognized prior to surgery and its effects on baseline measures should be considered.